Linnea®
Vincamine

PLANT

Voacanga africana

PART OF THE PLANT USED

Seeds

APPEARANCE

White crystalline microcrystalline powder

CAS NUMBER

1617-90-9


Linnea’s Vinpocetine and Vincamine are extracted from the seeds of Voacanga africana (a plant native to sub-Saharan Africa), known for their high concentration of alkaloids


Products


Pharmaceutical use

  • Cerebral circulation modulation
  • Dizziness, vertigo (Ménière disease)

Dietary use

  • * In accordance with Swiss law and under a self-regulation system, Linnea ensures compliance with applicable regulations in the destination countries of its products before export

Key Insights

  • Complies with Ph. Eur. “Vinpocetine” monograph, current edition
  • Linnea’s product is sourced from the wild from West and Central Africa regions
  • Seeds are carefully harvested, ensuring minimal environmental impact
  • Linnea is the official supplier to EDQM for Ph. Eur. analytical standard for Vinpocetine
The logo indicates that, while producing Vincamine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.
Sustainably sourced

Sustainably sourced

Sustainably harvested seeds

Sustainably harvested seeds

The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing Vincamine.
The logo indicates that Linnea is CEP certified for producing Vincamine. CEP stands for Certificate of Suitability to the monographs of the European Pharmacopoeia.
The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing Vincamine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.

Education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

Get the latest
Linnea® news